HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis

por Fleites, Yoel A, Aguiar, Jorge, Cinza, Zurina, Bequet, Monica, Marrero, Elieser, Vizcaíno, Maritania, Esquivel, Idelsis, Diaz, Marisol, Sin-Mayor, Adriana, Garcia, Maura, Martinez, Sara M, Beato, Abrahan, Galarraga, Ana G, Mendoza-Mari, Yssel, Valdés, Iris, García, Gerardo, Lemos, Gilda, González, Isabel, Canaán-Haden, Camila, Figueroa, Nelvis, Oquendo, Rachel, Akbar, Sheikh MF, Mahtab, Mamun A, Uddin, Mohammad H, Guillén, Gerardo E, Muzio, Verena L, Pentón, Eduardo, Aguilar, Julio C
Publicado 2021